{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:51:16Z","timestamp":1792291876949,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Vetmedica Japan Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.resinv.2026.101491","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:10:46Z","timestamp":1785355846000},"page":"101491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Divergent plasma lipidomic signatures characterizing the pathophysiological heterogeneity of COPD and pulmonary fibrosis"],"prefix":"10.1016","volume":"64","author":[{"given":"Kayako","family":"Suda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5411-7739","authenticated-orcid":false,"given":"Yasuo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3384-4354","authenticated-orcid":false,"given":"Yasuhiro","family":"Horibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Domae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-5750","authenticated-orcid":false,"given":"Yusuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9480-5923","authenticated-orcid":false,"given":"Seiji","family":"Niho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3291-0821","authenticated-orcid":false,"given":"Akimitsu","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0529-1554","authenticated-orcid":false,"given":"Ko","family":"Igami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101491_bib1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1164\/rccm.202209-1795CI","article-title":"Differential diagnosis of suspected chronic obstructive pulmonary disease exacerbations in the acute care setting: best practice","volume":"207","author":"Celli","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101491_bib2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.2024.3669","article-title":"Interstitial lung disease: a review","volume":"331","author":"Maher","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2026.101491_bib3","series-title":"GOLD report","year":"2015"},{"key":"10.1016\/j.resinv.2026.101491_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00439-024-02696-9","article-title":"Genome-wide assessment of shared genetic landscape of idiopathic pulmonary fibrosis and its comorbidities","volume":"143","author":"Yang","year":"2024","journal-title":"Hum Genet"},{"key":"10.1016\/j.resinv.2026.101491_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1465-9921-13-3","article-title":"The pathogenesis of COPD and IPF: distinct horns of the same devil?","volume":"13","author":"Chilosi","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101491_bib6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1164\/rccm.202402-0313OC","article-title":"Development, progression, and mortality of suspected interstitial lung disease in COPDGene","volume":"210","author":"Rose","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101491_bib7","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1164\/rccm.202206-1041ST","article-title":"Syndrome of combined pulmonary fibrosis and emphysema: an official ATS\/ERS\/JRS\/ALAT research statement","volume":"206","author":"Cottin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101491_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100404","article-title":"Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment","volume":"7","author":"Conte","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.resinv.2026.101491_bib9","first-page":"8617","article-title":"Clinical efficacy and safety of ICS\/LABA in patients with combined idiopathic pulmonary fibrosis and emphysema","volume":"8","author":"Dong","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.resinv.2026.101491_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/resp.13530","article-title":"Metabolomics in chronic lung diseases","volume":"25","author":"Nambiar","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101491_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12931-022-02006-9","article-title":"Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype","volume":"23","author":"Guiot","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101491_bib12","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","article-title":"Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity","volume":"81","author":"Yoon","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.resinv.2026.101491_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202000039","article-title":"Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis","volume":"15","author":"Nambiar","year":"2021","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.resinv.2026.101491_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2020-215892","article-title":"Ceramide and sphingosine-1 phosphate in COPD lungs","author":"Berdyshev","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2026.101491_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12931-025-03239-0","article-title":"Dysregulated metabolic pathways of pulmonary fibrosis and the lipids associated with the effects of nintedanib therapy","volume":"26","author":"Shimizu","year":"2025","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101491_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101491_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1378\/chest.96.1.68","article-title":"New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6","volume":"96","author":"Kohno","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101491_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1440-1843.2006.00834.x","article-title":"Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis","volume":"11","author":"Yokoyama","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101491_bib19","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1038\/s41598-022-12399-8","article-title":"Baseline serum Krebs von den Lungen-6 as a biomarker for the disease progression in idiopathic pulmonary fibrosis","volume":"12","author":"Chung","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101491_bib20","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/crj.12946","article-title":"The serum KL-6 levels in untreated idiopathic pulmonary fibrosis can naturally decline in association with disease progression","volume":"12","author":"Ishii","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.resinv.2026.101491_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01557-2025","article-title":"Progressive pulmonary fibrosis: a state-of-the-art review","author":"Cottin","year":"2026","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101491_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/his.70167","article-title":"The 2025 ATS\/ERS update of the international multidisciplinary classification of the interstitial pneumonias: implications for the pathologist","author":"Nicholson","year":"2026","journal-title":"Histopathology"},{"key":"10.1016\/j.resinv.2026.101491_bib23","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/Bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.resinv.2026.101491_bib24","doi-asserted-by":"crossref","first-page":"W501","DOI":"10.1093\/nar\/gkx372","article-title":"Pathview web: user friendly pathway visualization and data integration","volume":"45","author":"Luo","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.resinv.2026.101491_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.resinv.2026.101491_bib26","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.resinv.2026.101491_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11745-011-3589-2","article-title":"2-Polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice","volume":"46","author":"Hung","year":"2011","journal-title":"Lipids"},{"key":"10.1016\/j.resinv.2026.101491_bib28","article-title":"Switch-like methylation of functional pathways distinguishes COPD and idiopathic pulmonary fibrosis","author":"Shutta","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.resinv.2026.101491_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3164\/jcbn.21-121","article-title":"Metabolic changes induced by TGF-\u03b21 via reduced expression of phosphatidylserine decarboxylase during myofibroblast transition","volume":"70","author":"Uchida","year":"2022","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.resinv.2026.101491_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12931-023-02644-7","article-title":"Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry","volume":"25","author":"Summer","year":"2024","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101491_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1164\/rccm.201410-1771OC","article-title":"Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes","volume":"191","author":"Bowler","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101491_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12070621","article-title":"Metabolome features of COPD: a scoping review","volume":"12","author":"Godbole","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.resinv.2026.101491_bib33","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1111\/all.15432","article-title":"Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis","volume":"77","author":"Berdyshev","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.resinv.2026.101491_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101491_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.opresp.2023.100233","article-title":"Combined pulmonary fibrosis and emphysema syndrome: what is the role of airflow limitation?","volume":"5","author":"Moya-\u00c1lvarez","year":"2023","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.resinv.2026.101491_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/COPD.S229505","article-title":"Plasma metabolomics and lipidomics reveal perturbed metabolites in different disease stages of chronic obstructive pulmonary disease","volume":"15","author":"Zhou","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.resinv.2026.101491_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.646010","article-title":"Serum glycerophospholipid profile in acute exacerbation of chronic obstructive pulmonary disease","volume":"12","author":"Gai","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.resinv.2026.101491_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism","volume":"43","author":"Geer","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.resinv.2026.101491_bib39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12931-022-02164-w","article-title":"Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate\/vilanterol: a randomized controlled trial","volume":"23","author":"Daley-Yates","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101491_bib40","doi-asserted-by":"crossref","first-page":"11629","DOI":"10.1021\/acs.analchem.9b02045","article-title":"Lipid coverage in nanospray desorption electrospray ionization mass spectrometry imaging of mouse lung Tissues","volume":"91","author":"Nguyen","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.resinv.2026.101491_bib41","series-title":"Phospholipid metabolism in stem cells and its application to the pathophysiological analysis","first-page":"1157","author":"Shimizu","year":"2024"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:26:44Z","timestamp":1791502004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2212534526001255"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101491","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergent plasma lipidomic signatures characterizing the pathophysiological heterogeneity of COPD and pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101491"}}